Trastuzumab and Biosimilars

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.206
Version
20200902
PublisherAmerican Society of Clinical Oncology StewardDate2020-09-02T01:00:26-04:00Purpose

(Clinical Focus: This value set contains concepts that represent the medication Trastuzumab and Trastuzumab biosimilars.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Trastuzumab and Trastuzumab biosimilars.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)

Expansion
<<>>>
CodeDisplaySystem
2257297http://www.nlm.nih.gov/research/umls/rxnorm
2383305http://www.nlm.nih.gov/research/umls/rxnorm
2472791http://www.nlm.nih.gov/research/umls/rxnorm
2289234http://www.nlm.nih.gov/research/umls/rxnorm
1658084http://www.nlm.nih.gov/research/umls/rxnorm
2179760http://www.nlm.nih.gov/research/umls/rxnorm
2267576http://www.nlm.nih.gov/research/umls/rxnorm
2107053http://www.nlm.nih.gov/research/umls/rxnorm
1922516http://www.nlm.nih.gov/research/umls/rxnorm
1658089http://www.nlm.nih.gov/research/umls/rxnorm
2179753http://www.nlm.nih.gov/research/umls/rxnorm
2382604http://www.nlm.nih.gov/research/umls/rxnorm
2174804http://www.nlm.nih.gov/research/umls/rxnorm
2280732http://www.nlm.nih.gov/research/umls/rxnorm
2119714http://www.nlm.nih.gov/research/umls/rxnorm
2289227http://www.nlm.nih.gov/research/umls/rxnorm
1922509http://www.nlm.nih.gov/research/umls/rxnorm
2169359http://www.nlm.nih.gov/research/umls/rxnorm